Product-line extensions and pricing strategies of brand-name drugs facing patent expiration.

Journal of managed care pharmacy : JMCP

Volumn 11, Issue 9, 2005, Pages 746-754

  Hong, Song Hee ^a   Shepherd, Marvin D ^a   Scoones, David ^a   Wan, Thomas T H ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; COST; DRUG COST; DRUG INDUSTRY; ECONOMIC ASPECT; ECONOMICS; FOLLOW UP; HUMAN; PATENT; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES;

COSTS AND COST ANALYSIS; DRUG COSTS; DRUG INDUSTRY; DRUGS, GENERIC; ECONOMIC COMPETITION; FOLLOW-UP STUDIES; HUMANS; PATENTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 33644837856     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2005.11.9.746     Document Type: Article

References (0)